Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma (Q40817778)

24 September 2017

title

Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma (English)

1 reference

24 September 2017

Paterson IC

1

1 reference

24 September 2017

Matthews JB

2

1 reference

24 September 2017

Huntley S

3

1 reference

24 September 2017

Robinson CM

4

1 reference

24 September 2017

Fahey M

5

1 reference

24 September 2017

Parkinson EK

6

1 reference

24 September 2017

Prime SS

7

1 reference

24 September 2017

publication date

1 April 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

193

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

458-467

1 reference

TGF-beta receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

The behaviour of human oral squamous cell carcinoma in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Insulin-stimulated expression of c-fos, fra1 and c-jun accompanies the activation of the activator protein-1 (AP-1) transcriptional complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Genetic events and the role of TGF beta in epithelial tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Development of TGF-beta resistance during malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Characterization of the promoter region of the human transforming growth factor-beta type II receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH822%3E3.0.CO%3B2-V

10.1002/1096-9896(2000)9999:9999<::AID-PATH822>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference